Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-25-008956
Filing Date
2025-03-24
Accepted
2025-03-24 16:03:40
Documents
112
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K clnn20241231_10k.htm   iXBRL 10-K 2991326
2 EXHIBIT 4.1 ex_781217.htm EX-4.1 33531
3 EXHIBIT 19.1 ex_787371.htm EX-19.1 72017
4 EXHIBIT 21.1 ex_726995.htm EX-21.1 5660
5 EXHIBIT 23.1 ex_726996.htm EX-23.1 2536
6 EXHIBIT 31.1 ex_726997.htm EX-31.1 12689
7 EXHIBIT 31.2 ex_726998.htm EX-31.2 12554
8 EXHIBIT 32.1 ex_726999.htm EX-32.1 5996
9 EXHIBIT 32.2 ex_727000.htm EX-32.2 5868
15 fig7_25pct.jpg GRAPHIC 33037
16 fig8_35pct.jpg GRAPHIC 21873
17 fig10.jpg GRAPHIC 65180
18 figure1v3.jpg GRAPHIC 27533
19 figure2v2.jpg GRAPHIC 49943
20 figure3full.jpg GRAPHIC 57865
21 figure4v2.jpg GRAPHIC 83869
22 figure5av2.jpg GRAPHIC 37785
23 figure5bv3.jpg GRAPHIC 54445
24 figure6v3.jpg GRAPHIC 56767
25 figure9v2.jpg GRAPHIC 73475
26 pipelinejan2025_22pct.jpg GRAPHIC 109216
  Complete submission text file 0001437749-25-008956.txt   14903899

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA clnn-20241231.xsd EX-101.SCH 108347
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clnn-20241231_cal.xml EX-101.CAL 76775
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20241231_def.xml EX-101.DEF 687114
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20241231_lab.xml EX-101.LAB 646486
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20241231_pre.xml EX-101.PRE 733602
115 EXTRACTED XBRL INSTANCE DOCUMENT clnn20241231_10k_htm.xml XML 2206095
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39834 | Film No.: 25764111
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)